Bobby Chacko

1.2k citations
52 papers · 872 · 2 hit papers · h-index 16

Impact in

  • Nephrology top 2%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
    • Renal Transplantation Outcomes and Treatments

Papers in

    • Renal Diseases and Glomerulopathies 15
    • Acute Kidney Injury Research 5
    • Dialysis and Renal Disease Management 5
    • Chronic Kidney Disease and Diabetes 3
    • Renal Transplantation Outcomes and Treatments 4

Bobby Chacko

43 papers receiving 828 citations

Bobby Chacko's Hit Papers

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial 2023 · 142 citations
1420+1+2Years since publication4080120

Peers

Bobby Chacko
Comparison fields: 5 of 81
  • Nephrology 387
  • Transplantation 49
  • Endocrinology, Diabetes and Metabolism 125
  • Hematology 61
  • Parasitology 36
Replace Ahmed M. Alkhunaizi with:
Ahmed M. Alkhunaizi Saudi Arabia
Amitabh Gautam United States
Izzet Hakki Arikan Türkiye
Jerko Barbić Croatia
In O Sun South Korea
Ramanathan Sakthirajan India
Seungyeup Han South Korea
C Svalander Sweden
Ahmed Ibrahim Kamal Egypt
Paul B. Rylance United Kingdom
Bobby Chacko relative to Ahmed M. Alkhunaizi Saudi Arabia Ahmed M. Alkhunaizi's profile →
Citations per field
00.5×5×10×16×
Ahmed M. Alkhunaizi · 1×
Citations per year

Countries citing papers authored by Bobby Chacko

Since Specialization
Citations

This map shows the geographic impact of Bobby Chacko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Chacko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Chacko more than expected).

Fields of papers citing papers by Bobby Chacko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobby Chacko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Chacko. The network helps show where Bobby Chacko may publish in the future.

Co-authors

The 25 scholars most cited alongside Bobby Chacko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bobby Chacko Line = papers co-authored together Bobby Chacko links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
Hit paper breakdown →
2023142
2
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Hit paper breakdown →
2023140
3 200692
4 201149
5 201943
6 200740
7 200537
8 201429
9 200429
10 201829
11 200627
12 201722
13 200722
14 202518
15 202317
16 201817
17 201816
18 200711
19 201111
20 202210

About Bobby Chacko

Bobby Chacko is a scholar working on Nephrology, Transplantation, Pulmonary and Respiratory Medicine, Hematology and Parasitology, having authored 52 papers that have together received 872 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (15 papers), Acute Kidney Injury Research (5 papers), Dialysis and Renal Disease Management (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Platelet Disorders and Treatments (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Organ Donation and Transplantation (3 papers). The work is most often cited by research in Nephrology (387 citations), Transplantation (49 citations), Endocrinology, Diabetes and Metabolism (125 citations), Hematology (61 citations) and Parasitology (36 citations). Bobby Chacko has collaborated with scholars based in Australia, India and United States. Frequent co-authors include George Tharayil John, Chakko Korula Jacob, M.G. Kirubakaran, Anila Korula, Mohit Mathur, Kook‐Hwan Oh, Tak Mao Chan, Laura Ann Kooienga, Tom Lea‐Henry and Jill Yarbrough. Their work appears in journals such as Nephrology, Transplantation, Kidney International Reports, Flora and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact